Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (3)
  • 2025 (1)
  • 2024 (3)
  • 2023 (4)
  • 2022 (7)
  • 2021 (2)

Subject

  • Drug Trafficking (105)
  • Guilty Plea (43)
  • Guns/Weapons (39)
  • Outreach/Drug Prevention (39)
  • Synthetic drugs (38)
  • Take Back Day (34)
  • Arrests/Convictions - Major (33)
  • Fake Pills (33)
  • Fentanyl Awareness (30)
  • HIDTA (29)
  • Prescription Drugs (28)
  • Seizures (Drugs/Property) (26)
  • Task Forces/Task Force Officers (24)
  • Gangs (23)
  • One Pill Can Kill (20)
  • Overdose (19)
  • OCDETF/Task Force (18)
  • Pharmaceuticals/Pharmacists/Physicians (15)
  • Prevention/Education - DEA websites GSAD, JTT etc (14)
  • Red Ribbon (12)
  • Counterfeit Pills (11)
  • Fentanyl Free America (10)
  • Major Law Enforcement Operation (10)
  • Money Laundering (10)
  • Press Conferences (9)
  • Public and Media Affairs - also see Congressional Affairs (8)
  • International/Foreign Operations (4)
  • Campaigns (2)
  • Dark Web- Internet Trafficking (2)
  • Extraditions (2)
  • Intergovernmental Affairs (1)
  • Narcoterrorism (1)
  • Other (1)
  • Recruitment/Office of Training/Graduations (1)
  • Terrorism (1)
  • Diversion Division (20)

Drug Name

  • Oxycodone (4)

Field Division

  • Atlanta (13)
  • Chicago (18)
  • Dallas (6)
  • Detroit (1)
  • El Paso (11)
  • Houston (17)
  • Los Angeles (4)
  • Louisville (3)
  • Miami (11)
  • New England (36)
  • New Jersey (16)
  • New Orleans (8)
  • New York (28)
  • Omaha (4)
  • Phoenix (4)
  • Rocky Mountain (7)
  • San Diego (3)
  • San Francisco (10)
  • Seattle (25)
  • Sede (11)
  • St. Louis (11)
  • Washington, DC (34)
Clear All Results
20 Results - Showing 1 to 10
PRESS RELEASE

DEA and United Against Fentanyl Announce National Partnership for Walk for Lives 2026

NEWARK, N.J. –The U.S. Drug Enforcement Administration and United Against Fentanyl (UAF) announced a national partnership in support of DEA’s Fentanyl Free America initiative. Walk for Lives 2026 is a coordinated series of more than 100 family-led community events across the United States on July 11, 2026. These events aim...
PRESS RELEASE

Camden County Pharmacist Charged with Illegally Dispensing Oxycodone

CAMDEN, N.J. – Special Agent in Charge of the Drug Enforcement Administration's New Jersey Field Division Towanda R. Thorne-James and U.S. Attorney for the District of New Jersey Robert Frazer announced a Camden County pharmacist was charged in an indictment with unlawfully distributing oxycodone, and his wife was separately charged...
PRESS RELEASE

Iowa Pharmacist Who Stole Controlled Substances Sentenced

CEDAR RAPIDS, Iowa- A licensed pharmacist who created fake patient profiles to steal prescription drugs containing controlled substances was sentenced on April 15, to a three‑year term of probation. Ryan Paul Etscheid, age 40, from La Salle, Illinois, received the sentence after an October 27, 2025, guilty plea to acquiring...
PRESS RELEASE

DEA Omaha Division Safely Disposes of 20,628 Pounds of Unused Medications on 28th National Prescription Drug Take Back Day

OMAHA, Neb – The Drug Enforcement Administration (DEA) Omaha Division joined forces with 155 law enforcement agencies across the five-state region to safely dispose of 20,628 pounds of unneeded and expired medications at the 28th National Prescription Drug Take Back Day, April 26. Nationally, more than 620,000 pounds of prescription...
PRESS RELEASE

Members of a Houston-Based Organization Responsible for Breaking Into Pharmacies in Rural Iowa and Nebraska Indicted

OMAHA, Neb – Five members of a Houston-based organization known for targeting rural pharmacies in Western Iowa and Western Nebraska face federal charges after breaking in and stealing pharmaceuticals in May and June of 2022 and 2023. These five people are part of a larger conspiracy being prosecuted out of...
PRESS RELEASE

Drug Manufacturer to Pay $2.25 Million to Settle Substances Act Allegations

NEWARK, N.J. – A pharmaceutical manufacturer agreed to pay $2.25 million to resolve allegations that it violated the Controlled Substances Act (CSA), DEA New Jersey Field Division Special Agent in Charge Cheryl Ortiz and U.S. Attorney Philip R. Sellinger announced today The manufacturer, Novel Laboratories Inc. (Novel), a subsidiary of...
PRESS RELEASE

Owner Of New Jersey Company Admits to Evading U.S. Customs Duties and His Company Agrees to a $3.1 Million Settlement Agreement

NEWARK, N.J. – The owner of a New Jersey company today admitted mislabeling hazardous chemicals entering the United States and evading customs duties, DEA New Jersey Field Division Special Agent in Charge Cheryl Ortiz and U.S. Attorney Philip R. Sellinger announced today. George Volpe, 60, of Roseland, New Jersey, owner...
PRESS RELEASE

Passaic County Doctor Charged in Conspiracy to Distribute Opioids

NEWARK, N.J. – A Passaic County, New Jersey, doctor was charged with conspiring to distribute opioids without a legitimate medical reason, Special Agent in Charge of the Drug Enforcement Administration’s (DEA) New Jersey Field Division Cheryl Ortiz and U.S. Attorney Philip R. Sellinger announced. Lisa Ferraro, 65, of Hillsdale, New...
PRESS RELEASE

Toms River Woman Charged with Unauthorized Practice of Medicine, Forgery, Health Care Claims Fraud, and Distribution of a Controlled Dangerous Substance

NEWARK, N.J. – Special Agent in Charge of the Drug Enforcement Administration’s (DEA) New Jersey Division Cheryl Ortiz and Ocean County Prosecutor Bradley D. Billhimer announced that on July 25, 2023, Maria F. Macburnie, aka Marife L. Macburnie, 62, of Toms River, was charged with Practicing Medicine by an Unlicensed...
PRESS RELEASE

Gloucester County Man Admits Healthcare Fraud

CAMDEN, N.J. – A Gloucester County, New Jersey, man today admitted defrauding his employer’s health insurance plan out of more than $4 million by submitting fraudulent claims for medically unnecessary compounded medications, Special Agent in Charge of the Drug Enforcement Administration’s New Jersey Division Cheryl Ortiz and Attorney for the...

Paginación

  • Current page 1
  • Página 2
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster